Navigation Links
Helix BioPharma to Present at the BioFinance 2009 Conference
Date:4/24/2009

AURORA, Ontario, April 24 /PRNewswire/ -- Helix BioPharma Corp. (TSX, FSE: "HBP") today announced that John Docherty, president and chief operating officer, will present at the BioFinance 2009 Investor Conference at 3:00 p.m. EDT on Wednesday, April 29, at The Toronto Marriott in Toronto. Mr. Docherty will provide an overview of the company's leading technology platforms, DOS47 and Biphasix(TM), and its current product development programs, L-DOS47 and Topical Interferon Alpha-2b. The slide show portion of the presentation will be posted on the Company's website, www.helixbiopharma.com, on April 29, 2009.

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX under the symbol "HBP".

    For further information contact:

    Investor & Media Relations
    Ian Stone                           Robert Flamm, Ph.D.
    Russo Partners LLC                  Russo Partners LLC
    Tel: (619) 814-3510                 Tel: (212) 845-4226
    Fax: (619) 955-5318                 Email:
    Email:                               robert.flamm@russopartnersllc.com
     ian.stone@russopartnersllc.com     www.russopartnersllc.com

This News Release contains certain forward-looking statements regarding the Company's planned presentation at the BioFinance 2009 Investor Conference and the Company's research and development initiatives, which statements can be identified
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. Helix BioPharma announces Q1 2008 financial results
7. Helix BioPharma closes $16.9 million private placement of common shares
8. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
9. Helix BioPharma shareholders vote in favour of management
10. Helix BioPharma reports Q2 2008 highlights, financial results
11. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2013)... CA (PRWEB) May 25, 2013 Dennis R. ... Center in Oakland, CA reports that recently there has been ... 131 has markedly improved the permanent seed, or low dose ... newer isotope has a higher energy, a shorter half life, ... It is true that Cesium 131 has a higher average ...
(Date:5/24/2013)... SAN DIEGO , May 24, 2013 ... a  company using proprietary taste science technologies to discover, ... David Linemeyer , Ph.D., the Company,s ... , Vice President, Investor Relations & Corporate Communications, will ... Friday, May 31, at 10:25 a.m. Eastern Time (7:25 ...
(Date:5/24/2013)... Madison, WI (PRWEB) May 24, 2013 ... to the discovery and development of calcium-binding proteins ... publication of safety assessment study of apoaequorin ... an international journal published for the British Industrial ... the study was to investigate potential adverse effects, ...
(Date:5/23/2013)... Can economic incentives such as gift cards, T-shirts, ... public to increase their donations of blood? , A ... School Assistant Professor Mario Macis says the answer ... of recent research that supports their argument, the three ... Science that the World Health Organization and national blood ...
Breaking Biology Technology:Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 2Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 3SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CITI 2013 GLOBAL CONSUMER CONFERENCE 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3
... , The QIAGEN QuickLyse ... preparation of up to 15 g plasmid DNA. The quality of the DNA ensures , ... and cloning. , ... include: , One-step lysis reduced ...
... Kodak Molecular Imaging Systems introduces a line of small-animal , ... level of molecular , signal localization in ... precise multi-modal coregistration of optical or radioisotopic molecular , ... , ...
... , ... of the sample, leading to changes in the gene,expression profile. ... RT-PCR and microarray analysis,it is important to stabilize the RNA ... RNA from animal tissues, bacteria, and human blood and now ...
Cached Biology Technology:QuickLyse Miniprep Kit 2Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals 2Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals 3Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals 4Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals 5Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals 6Successful stabilization of gene expression profiles 2Successful stabilization of gene expression profiles 3
(Date:5/22/2013)... A new, streamlined approach to genetic engineering drastically ... new genes into bacteria, the workhorses of biotechnology, ... ACS Synthetic Biology , the method paves the ... for drug development, environmental cleanup and other activities. ... or integrating, a piece of the genetic material ...
(Date:5/22/2013)... feared Legionella pneumophila bacteria is responsible for ... In order to infect us, this pathogen has developed ... go unnoticed in our cells, thus avoiding these acting ... Basque biosciences research centre, CIC bioGUNE, in which teams ... USA and the National Supercomputation Centre in Barcelona (BSC) ...
(Date:5/22/2013)... pollinating insects and wild plants have slowed in recent ... by the University of Leeds and the Naturalis Biodiversity ... reductions in the diversity of species in Britain, Belgium ... But the picture brightened markedly after 1990, with a ... hoverflies and wild plants. , Professor Bill ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
... Lake Tanganyika has a highly diverse fauna which closely resembles ... traced the origins of the freshwater herring of the Lake ... to 50 million years ago, coincident with a major oceanic ... organisms may help to explain the origins of other species ...
... billion pairs of molecules that form the rungs of the ... the DNA they comprise transmits traits across generations in a ... sequence of letters in the code. ... is the physical manner in which DNA is spun around ...
... origins of life and culminating with the latest findings ... will report on research spanning three billion years of ... symposium takes place on Thursday, May 1, and Friday, ... is free and open to the public. The ...
Cached Biology News:Freshwater herring had salty origin 2Scientists clarify a mechanism of epigenetic inheritance 2Scientists clarify a mechanism of epigenetic inheritance 3Rockefeller University hosts 2-day evolution symposium, May 1-2, 2008 2
...
Coverslips for Microarrays, 1. *Category: MICROARRAY ACCESSORIES....
... 0 (or Cap 0-like) RNA into Cap ... been shown to increase in vivo translation ... is seen in Cap 0 structures created ... well as those Cap 0 structures created ...
Form: Ready to use Applications: ELISA...
Biology Products: